DDX23
Basic information
Region (hg38): 12:48829756-48852842
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DDX23 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 53 | 59 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 2 | 3 | 58 | 2 | 1 |
Variants in DDX23
This is a list of pathogenic ClinVar variants found in the DDX23 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-48830495-G-A | Congenital bilateral perisylvian syndrome | Likely pathogenic (Dec 01, 2023) | ||
12-48830526-C-G | Uncertain significance (Mar 03, 2023) | |||
12-48830604-G-T | Inborn genetic diseases | Uncertain significance (Jun 10, 2024) | ||
12-48830630-G-A | Inborn genetic diseases | Uncertain significance (Mar 23, 2022) | ||
12-48830648-C-T | Uncertain significance (May 01, 2024) | |||
12-48830668-G-A | Conflicting classifications of pathogenicity (Nov 10, 2020) | |||
12-48831190-G-C | DDX23-related disorder | Uncertain significance (Jan 18, 2024) | ||
12-48831199-T-C | Inborn genetic diseases | Uncertain significance (May 11, 2022) | ||
12-48831248-CTTGAGG-C | Pathogenic (Oct 28, 2022) | |||
12-48831250-T-C | Likely pathogenic (Oct 28, 2022) | |||
12-48831253-G-A | Inborn genetic diseases | Uncertain significance (May 25, 2022) | ||
12-48831312-T-C | Inborn genetic diseases | Uncertain significance (Apr 25, 2023) | ||
12-48832465-G-A | Neurodevelopmental disorder | Likely pathogenic (Sep 02, 2022) | ||
12-48832491-A-C | Fetal growth restriction;Motor delay;Failure to thrive;Abnormal facial shape | Conflicting classifications of pathogenicity (Jul 20, 2021) | ||
12-48832501-C-T | Uncertain significance (May 01, 2024) | |||
12-48832565-C-A | Uncertain significance (Aug 10, 2020) | |||
12-48833358-G-T | Pathogenic (Apr 17, 2024) | |||
12-48833434-T-A | Uncertain significance (Aug 10, 2020) | |||
12-48833495-A-C | Inborn genetic diseases | Uncertain significance (Jan 23, 2023) | ||
12-48833497-C-T | Intellectual disability | Uncertain significance (Aug 10, 2020) | ||
12-48833498-G-A | Uncertain significance (Aug 10, 2020) | |||
12-48834399-G-A | Inborn genetic diseases | Uncertain significance (May 11, 2022) | ||
12-48834494-G-C | Inborn genetic diseases | Uncertain significance (Aug 13, 2021) | ||
12-48836142-G-A | DDX23-related Neurodevelopmental disorder | Uncertain significance (Jul 20, 2022) | ||
12-48836190-CCAGTCT-C | Uncertain significance (Apr 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DDX23 | protein_coding | protein_coding | ENST00000308025 | 16 | 23079 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.542 | 0.458 | 125727 | 0 | 21 | 125748 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.62 | 218 | 513 | 0.425 | 0.0000353 | 5365 |
Missense in Polyphen | 22 | 143.64 | 0.15316 | 1654 | ||
Synonymous | 0.901 | 156 | 171 | 0.912 | 0.00000878 | 1604 |
Loss of Function | 5.15 | 11 | 50.5 | 0.218 | 0.00000378 | 504 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000242 | 0.000242 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in pre-mRNA splicing and its phosphorylated form (by SRPK2) is required for spliceosomal B complex formation. {ECO:0000269|PubMed:18425142}.;
- Pathway
- Spliceosome - Homo sapiens (human);Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.445
- rvis_EVS
- -0.98
- rvis_percentile_EVS
- 8.75
Haploinsufficiency Scores
- pHI
- 0.425
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.580
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.959
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ddx23
- Phenotype
Gene ontology
- Biological process
- cis assembly of pre-catalytic spliceosome;RNA splicing, via transesterification reactions;mRNA splicing, via spliceosome;RNA splicing
- Cellular component
- nucleus;nucleoplasm;U5 snRNP;nucleolus;extracellular exosome;catalytic step 2 spliceosome
- Molecular function
- RNA binding;ATP-dependent RNA helicase activity;protein binding;ATP binding;ATP-dependent helicase activity